Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-19
1993-02-23
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549315, 549316, 549317, A01N 4320, A01N 4324, C07D30512, C07D30793
Patent
active
051890577
ABSTRACT:
A compound of the formula (I): ##STR1## wherein R.sub.1 and R.sub.2 each is a hydrocarbon residue, R.sub.3 is a sulfo group or phosphono group, --CO--R.sub.4 is an esterified carboxyl group, a thiol-esterified carboxyl group or an amidated carboxyl group; and .about. represents the absolute configuration of R or S, or its salt, which is useful for preventing and treating thrombosis.
REFERENCES:
patent: 5043459 (1991-08-01), Matsumura et al.
Plough et al., Biochimica et Biophysicia Acta, vol. 24, pp. 278-282 (1957).
Rijken et al., The Journal of Biological Chemistry, vol. 256, No. 13, (Jul. 10, 1981), pp. 7035-7041.
Jukes, Trends in Biochemical Sciences, vol. 4, No. 1 (Jan. 1979).
Pannell et al., Blood, vol. 67, No. 5 (May 1986) pp. 1215-1223.
Tengborn, Fibrinolysis, vol. 1 (1987) pp. 24-32.
Kato Koichi
Masuya Hirotomo
Norihiko Moriya
Covington Raymond
Ivy C. Warren
Takeda Chemical Industries Ltd.
LandOfFree
Saccharoascorbic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Saccharoascorbic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saccharoascorbic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2205194